Poland: A Sleeping Giant
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
Address: ul. Jutrzenki 94
02-230 Warszawa
Tel: +48 22 824 97 32
Web: http://www.blaufarma.pl/?pId=produkty_glowna
Founded in 2001, BLAU FARMA is Polish private specialty pharmaceutical company focused on dermatology.
The company is centered on development, manufacturing and marketing of innovative, safe and effective prescription and over-the-counter preparations that importantly improve the lives of patients suffering from conditions related to skin diseases (such as acne, steroid-sensitive dermatoses, fungal and bacterial infections), as well as dermocosmetics lines of products that aid each individual to optimize their skin’s health.
The second BLAU FARMA’s business area is parallel import of medicinal products. Today, the company is parallel importer No 3 in Poland. We strongly believe that stimulating competition in the pharmaceutical market enables broader access to better treatment options for greater number of patients.
Quality is a cornerstone of all BLAU FARMA’s of activities. The company seeks the highest quality information, decisions and people, and produces high quality products.
BLAU FARMA’s goal is to become the number one in Poland among dermatology-focused pharmaceutical companies and to enter European export markets.
With the headquarter in Warsaw, BLAU FARMA employs 56 highly skilled and efficient full-time employees.
The company holds integrity, responsibility and professionalism above all else. Also cherishes hard work, productivity, loyalty, accountability, leadership, teamwork, creativity, initiative, courage, enthusiasm and optimism.
Prescription and non prescription pharmaceutical in dermatology.
Parallel imports of dermatology products as well as expanding ophthamological products.
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
Voivodeships, Polish expenditure on health care system per one resident is still below the European average. In regards to the issue concerning the „expenditure on health care system”, I would…
Would you start by giving our readers a brief outline of the history of the PRI? In 1952 the institute was established as a research and development (R&D) centre for…
You became president of the board at Medicover in Poland only a while ago and previously your previous experience was in high-profile management but not in healthcare. Do you now…
IMS ‘lives and breathes the pharma industry’ and it is stimulating to come from other forms of consultancy to IMS. You have worked in various businesses. What motivated you to…
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
As we are just entering 2011, could you share with us the results of the Polish affiliate in 2010? 2010 was for Ferring Poland a year of reconstruction. The affiliate…
Adamed was founded in 1986 by your father, Mr. Marian Adamkiewicz. The company is today still fully-owned by your family, which is remarkable in such an industry, where family-run businesses…
You joined Merck in September 1996, took gradually increasing positions at Merck, from Medical Representative (1996 – 1998), to Sales and Marketing managing positions and you were ultimately appointed Managing…
You have been appointed at the head of Pfizer Poland last December. 2010 is a hot year for the group – even very hot for some of the top management…
Apart from Poland being a 40 million population market, with double digit growth, Mr. Kuczynski of Pierre Fabre was telling us that the main opportunity of the Polish market lies…
What is PharmaExpert’s role in the Polish pharmaceutical industry? The information that PharmaExpert gathers enables us to give good insight about the evolution of the pharmacists market, the evolution of…
See our Cookie Privacy Policy Here
